2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice
Annals of the Rheumatic Diseases (ARD)
is a leading rheumatology journal from EULAR, publishing original research, reviews and recommendations
Impact Factor: 27.4
Citescore: 32.8
All metrics >>
Latest EULAR Recommendations
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Authors
Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.
The Author Information section provides general guidelines and requirements for specific article types.
Information is also provided on editorial policies and open access.
Latest Articles
Retraction:
Retraction: PKC{delta} null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth22 April 2024
Viewpoint:
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease18 April 2024
Autoimmunity:
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events12 April 2024
Recommendations
The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.
All EULAR recommendations are free to access.
Each recommendation also has an accompanying lay summary, which is also free to access.
Video
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis
Conclusion: Together, the findings imply costimulatory molecules as key regulators of cytotoxicity-driven pathology in systemic autoimmune disease, yielding CD7 as a novel target for selective depletion of pathogenic cells.
Find out moreAltmetrics
Jobs
London
We are looking for an experienced and committed occupational health consultant to develop and further enhance the Service provided to NHS staffRecruiter: Barts Health NHS Trust
Consultant Plastic Surgeon w/i Skin Cancer & General Plastic Surgery
Prescot
Applicants are invited to apply for the whole-time position of Consultant Burns & Plastic Reconstruction Surgeon with an interest in Skin CancerRecruiter: Mersey and West Lancashire Teaching Hospitals NHS Trust
Consultant Plastic Surgeon Skin Cancer & Head & Neck Surgery Interest
Prescot
Applicants are invited to apply for the whole-time position of Consultant in Burns and Plastic Surgery with a Skin Cancer and Head & Neck OncologyRecruiter: Mersey and West Lancashire Teaching Hospitals NHS Trust
Consultant Psychiatrist - South Kent Coast CMHT Folkestone
Folkestone
Are you passionate about making a real impact on the lives of people with mental health needs? As a Consultant Psychiatrist at Kent and Medway NHS ...Recruiter: Kent and Medway NHS & Social Care Partnership Trust
Consultant Radiologist
Wrexham
Applications are invited for a Consultant Radiologist with a sub-specialty interest in Breast, GI, and oncology radiologyRecruiter: Betsi Cadwaladr University Health Board